MSTN and Insulin resistance: Decreased insulin resistance in myostatin deficient rats was attributed to a significant activation of the AMPK signaling pathway and increased adiponectin, an insulin sensitizing adipocytokine, secretion which enhances the oxidation of fatty acids in skeletal muscles.